PL2317998T3 - Kombinacja kwasu fulwowego i antybiotyku - Google Patents
Kombinacja kwasu fulwowego i antybiotykuInfo
- Publication number
- PL2317998T3 PL2317998T3 PL09757983.3T PL09757983T PL2317998T3 PL 2317998 T3 PL2317998 T3 PL 2317998T3 PL 09757983 T PL09757983 T PL 09757983T PL 2317998 T3 PL2317998 T3 PL 2317998T3
- Authority
- PL
- Poland
- Prior art keywords
- fulvic acid
- antibiotic combination
- antibiotic
- combination
- fulvic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/429—Thiazoles condensed with heterocyclic ring systems
- A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
- A61K31/431—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems containing further heterocyclic rings, e.g. ticarcillin, azlocillin, oxacillin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/7036—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin having at least one amino group directly attached to the carbocyclic ring, e.g. streptomycin, gentamycin, amikacin, validamycin, fortimicins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ZA200804901 | 2008-06-05 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2317998T3 true PL2317998T3 (pl) | 2016-11-30 |
Family
ID=40887008
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL09757983.3T PL2317998T3 (pl) | 2008-06-05 | 2009-06-04 | Kombinacja kwasu fulwowego i antybiotyku |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8445452B2 (pl) |
| EP (1) | EP2317998B1 (pl) |
| CN (1) | CN102099027B (pl) |
| BR (1) | BRPI0913586A8 (pl) |
| PL (1) | PL2317998T3 (pl) |
| RU (1) | RU2505295C2 (pl) |
| WO (1) | WO2009147635A1 (pl) |
| ZA (1) | ZA201008680B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0914966D0 (en) * | 2009-08-27 | 2009-09-30 | Natracine Uk Ltd | Fulvic acid compositions and their use |
| IN2014DN07194A (pl) * | 2012-03-07 | 2015-04-24 | Natracine Uk Ltd | |
| CN113813304A (zh) * | 2020-06-18 | 2021-12-21 | 陈信行 | 腐植酸山苍子复方及其制程 |
| CN111616358A (zh) * | 2020-06-20 | 2020-09-04 | 田劭军 | 一种用于提高免疫力的组合物及其应用 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5204368A (en) * | 1990-05-25 | 1993-04-20 | National Energy Council | Bacteriostatic and bacteriocidal method using fulvic acid derivatives |
| EP1700599B1 (en) * | 1998-10-08 | 2008-10-08 | Pfeinsmith Limited | Fulvic acid and its use in the treatment of candida infections |
| CN1120820C (zh) * | 1999-08-12 | 2003-09-10 | 河南省科学院生物研究所 | 健植液肥 |
| US8114910B2 (en) * | 2006-05-02 | 2012-02-14 | Pfeinsmith S.A. (Pty) Ltd. | Acidic composition |
| CN101129382B (zh) * | 2006-08-25 | 2013-12-25 | 天津和美生物技术有限公司 | 含β-内酰胺类抗生素和缓冲组分的抗生素复方 |
-
2009
- 2009-06-04 RU RU2010154511/15A patent/RU2505295C2/ru active
- 2009-06-04 CN CN2009801282464A patent/CN102099027B/zh active Active
- 2009-06-04 EP EP09757983.3A patent/EP2317998B1/en active Active
- 2009-06-04 US US12/996,480 patent/US8445452B2/en active Active
- 2009-06-04 WO PCT/IB2009/052366 patent/WO2009147635A1/en not_active Ceased
- 2009-06-04 BR BRPI0913586A patent/BRPI0913586A8/pt not_active Application Discontinuation
- 2009-06-04 PL PL09757983.3T patent/PL2317998T3/pl unknown
-
2010
- 2010-12-02 ZA ZA2010/08680A patent/ZA201008680B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US8445452B2 (en) | 2013-05-21 |
| CN102099027A (zh) | 2011-06-15 |
| CN102099027B (zh) | 2012-12-12 |
| RU2010154511A (ru) | 2012-07-20 |
| BRPI0913586A2 (pt) | 2015-10-27 |
| BRPI0913586A8 (pt) | 2018-03-13 |
| US20110207687A1 (en) | 2011-08-25 |
| RU2505295C2 (ru) | 2014-01-27 |
| EP2317998B1 (en) | 2016-04-20 |
| ZA201008680B (en) | 2012-03-28 |
| EP2317998A1 (en) | 2011-05-11 |
| WO2009147635A1 (en) | 2009-12-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL209141A0 (en) | Novel substituted pyridin-2-ones and pyridazin-3-ones | |
| IL210153A0 (en) | Nutrigenomics methods and compositions | |
| EP2483221A4 (en) | FERTILIZER COMPOSITIONS AND METHOD THEREFOR | |
| IL206929A0 (en) | Dilator | |
| IL212822A0 (en) | Anti-cxcr1 compositions and methods | |
| PT2374452T (pt) | Composição de nutrientes | |
| GB0819530D0 (en) | Methods and compositions | |
| GB0820262D0 (en) | Microorganisms | |
| GB0808575D0 (en) | Compilign and linking | |
| PL2294024T3 (pl) | Emalie i nośniki | |
| GB0821928D0 (en) | Antibiotic nanomaterial | |
| GB2455636B (en) | Trailers | |
| ZA201008680B (en) | Fulvic acid and antibiotic combination | |
| EP2320888A4 (en) | LAIDLOMYCIN COMPOSITIONS AND METHODS | |
| GB0810099D0 (en) | Final assemblies | |
| GB0811250D0 (en) | Methods and compositions | |
| GB0813359D0 (en) | Halfin and/or platerfin | |
| GB0817114D0 (en) | Composter | |
| AU2009904474A0 (en) | Composting | |
| GB0914966D0 (en) | Fulvic acid compositions and their use | |
| GB0820320D0 (en) | Biomaterials | |
| AU2009901914A0 (en) | Improvements in Composting | |
| AU2009905993A0 (en) | Nitrogen fertiliser use-efficiency | |
| AU2008900345A0 (en) | Improved Fertiliser | |
| GB0810835D0 (en) | Stake out |